Microbiological procedures for diagnosing mycoses and for antifungal susceptibility testing;Procedimientos de diagnóstico microbiológico de las micosis y estudios de sensibilidad a los antifúngicos

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 25, Issue 5, 2007, Pages 336-340

  Gadea, Ignacio ^a   Cuenca Estrella, Manuel ^b   Martín, Estrella ^c   Pemán, Javier ^d   Pontón, José ^e   Rodríguez Tudela, Juan Luis ^b  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Antifungal; Micoses

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; FLUTICASONE; ITRACONAZOLE; VORICONAZOLE;

CULTURE TECHNIQUE; DIAGNOSTIC ACCURACY; DRUG SENSITIVITY; FUNGAL DETECTION; HUMAN; IN VITRO STUDY; MYCOSIS; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 34547629415     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1157/13102270     Document Type: Review

References (19)

1. Merz WG, Roberts GD. Detection and recovery of fungi from clinical specimens. En: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology. Washington: American Society for Microbiology; 1999. p. 588-600.
2. Gadea I. Dermatomicosis y micosis tropicales. Medicine. Vol. 68. Barcelona: Ediciones Doyma S.L.; 2002. p. 47-56.
3. Gavaldà Santapau J, Ausina V. Infecciones por Aspergillus. Medicine. Vol. 68. Barcelona: Ediciones Doyma S.L.; 2002. p. 31-6.
4. Cuenca-Estrella M. Infecciones profundas por otros hongos patógenos humanos. Medicine. Vol. 68. Barcelona: Ediciones Doyma S.L.; 2002. p. 37-46.
5. Edson RS, Fernández-Guerrero ML, Roberts GD, Van Scoy RE. Clinical and laboratory features of cryptococcosis. A five-year experience. Minn Med. 1987;70:337-42.
6. Cuenca-Estrella M. Infecciones por Candida spp. Infecciones superficiales y profundas. Medicine. Vol. 68. Barcelona: Ediciones Doyma S.L.; 2002. p. 19-28.
7. Rex JH, Pfaller MA, Walsh TJ, Chaturvedi V, Espinel-Ingroff A, Ghannoum MA, et al. Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev. 2001;14:643-58.
8. De hoog GS, Guarro J. Atlas of clinical fungi: Centralbureau voor Schilmmelcultures/Universitat Rovira y Virgili. Baarn and Delf, The Netherlands, Universitat Rovira y Virgili, Reus, Spain, 2000.
9. Espinel-Ingroff A, Barchiesi F, Cuenca-Estrella M, Pfaller MA, Rinaldi M, Rodríguez-Tudela LJ, et al. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole. J Clin Microbiol. 2005;43:3884-9.
10. Gómez-López A, Aberkane A, Petrikkou E, Mellado E, Rodríguez-Tudela JL, Cuenca-Estrella M. Analysis of the influence of Tween concentration, inoculum size, assay medium, and reading time on susceptibility testing of Aspergillus spp. J Clin Microbiol. 2005;43:1251-5.
11. Rodríguez-Tudela JL, Cuenca-Estrella M, Rodero L, Carpintero Y, Gorgojo B. Influence of shaking on antifungal susceptibility testing of Cryptococcus neoformans: a comparison of the NCCLS standard M27A medium, buffered yeast nitrogen base, and RPMI-2% glucose. Antimicrob Agents Chemother. 2000;44:400-4.
12. Rodríguez-Tudela JL, Chryssanthou E, Petrikkou E, Mosquera J, Denning DW, Cuenca-Estrella M. Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi. J Clin Microbiol. 2003;41:5236-7.
13. Clinical Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard, M38-A: Wayne Pa, 2002.
14. Clinical Laboratory Standards Institute. Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts. Approved Guideline, M44-A: Wayne, Pa, 2004.
15. Maertens J, Deeren D, Dierickx D, Theunissen K. Preemptive antifungal therapy: still a way to go. Curr Opin Infect Dis. 2006;19:551-6.
16. Ponton J, Moragues MD, Quindos G. Non-culture based diagnostics. En: Calderone R, editor. Candida and Candidiasis. Vol. 1. Washington: American Society for Microbiology; 2002. p. 395-425.
17. Moragues MD, Ortiz N, Iruretagoyena JR, García-Ruiz JC, Amutio E, Rojas A, et al. Evaluación de una nueva técnica comercializada (Candida albicans IFA IgG) para el diagnóstico de la candidiasis invasiva. Enferm Infecc Microbiol Clin. 2004;22:83-8.
18. Prella M, Bille J, Pugnale M, Duvoisin B, Cavassini M, Calandra T, et al. Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies. Diagn Microbiol Infect Dis. 2005;51:95-101.
19. Sendid B, Tabouret M, Poirot JL, Mathieu D, Fruit J, Poulain D. New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J Clin Microbiol. 1999;37:1510-7.